Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Irritable Bowel Syndrome, July 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 86 articles:
HTML format


 

Single Articles

  1. GUO S, Lu Y, Xu B, Wang W, et al
    A Simple Fecal Bacterial Marker Panel for the Diagnosis of Crohn's Disease.
    Front Microbiol. 2019;10:1306.
    Abstract    

    Abstract available

  2. CHONG PP, Chin VK, Looi CY, Wong WF, et al
    The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy.
    Front Microbiol. 2019;10:1136.
    Abstract    

    Abstract available

  3. ZUO LG, Ge ST, Wang X, Zhu YK, et al
    [Analysis on prognosis and influencing factors of postoperative low anterior resection syndrome for rectal cancer patients undergoing laparoscopic anus-preserving radical resection].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2019;22:573-578.
    Abstract    

    Abstract available

  4. EL-SALHY M, Hausken T, Hatlebakk JG
    Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS).
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  5. WONG KMF, Yuen SSY, Mak ADP
    Neurocognitive Characteristics of Individuals with Irritable Bowel Syndrome.
    East Asian Arch Psychiatry. 2019;29:48-56.
    Abstract    

    Abstract available

  6. PUGLIESE G, Muscogiuri G, Barrea L, Laudisio D, et al
    Irritable bowel syndrome: a new therapeutic target when treating obesity?
    Hormones (Athens). 2019 Jun 21. pii: 10.1007/s42000-019-00113.
    Abstract    

    Abstract available

  7. SHAH C, Grover AS, Dhore P, Shukla A, et al
    Fecograph: A graphical representation of daily stool forms to subtype irritable bowel syndrome in office practice.
    JGH Open. 2019;3:224-227.
    Abstract    

    Abstract available

  8. MAGADMI R, Meszaros J, Damanhouri ZA, Seward EP, et al
    Secretion of Mast Cell Inflammatory Mediators Is Enhanced by CADM1-Dependent Adhesion to Sensory Neurons.
    Front Cell Neurosci. 2019;13:262.
    Abstract    

    Abstract available

  9. ROUDSARI NM, Lashgari NA, Momtaz S, Farzaei MH, et al
    Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review.
    Daru. 2019 Jul 4. pii: 10.1007/s40199-019-00284.
    Abstract    

    Abstract available

  10. CHOW CFW, Che S, Qin HY, Kwan HY, et al
    From psychology to physicality: how nerve growth factor transduces early life stress into gastrointestinal motility disorders later in life.
    Cell Cycle. 2019 Jul 4:1-6. doi: 10.1080/15384101.2019.1637203.
    Abstract    

    Abstract available

  11. JIA Z, Wang L, Yu B, Li Q, et al
    Association between polymorphisms in the serotonin transporter gene-linked polymorphic region and risk for irritable bowel syndrome in China: evidence based on a meta-analysis.
    J Int Med Res. 2019 Jul 5:300060519859144. doi: 10.1177/0300060519859144.
    Abstract    



  12. DUAN T, Cil O, Tse CM, Sarker R, et al
    Inhibition of CFTR-mediated intestinal chloride secretion as potential therapy for bile acid diarrhea.
    FASEB J. 2019 Jul 3:fj201901166R. doi: 10.1096/fj.201901166.
    Abstract    

    Abstract available

  13. RAVANBAKHSH N, Kesavan A
    The role of mast cells in pediatric gastrointestinal disease.
    Ann Gastroenterol. 2019;32:338-345.
    Abstract    

    Abstract available

  14. FARESJO A, Walter S, Norlin AK, Faresjo T, et al
    Gastrointestinal symptoms - an illness burden that affects daily work in patients with IBS.
    Health Qual Life Outcomes. 2019;17:113.
    Abstract    

    Abstract available

  15. STREGE PR, Mercado-Perez A, Mazzone A, Saito YA, et al
    SCN5A mutation G615E results in NaV1.5 voltage-gated sodium channels with normal voltage-dependent function yet loss of mechanosensitivity.
    Channels (Austin). 2019;13:287-298.
    Abstract    

    Abstract available

  16. PARK JY, Oh S, Han YM, Lee J, et al
    There might be a distinctive clinical phenotype of constipation with non-cardiac chest pain which responds to combination laxatives: A retrospective, longitudinal symptom analysis.
    Medicine (Baltimore). 2019;98:e15884.
    Abstract    

    Abstract available

  17. KONRAD P, Blonska A, Chojnacki J, Mikulska P, et al
    [Zaburzenia czynnosciowe przewodu pokarmowego u osob z przerostem bakteryjnym jelita cienkiego].
    Pol Merkur Lekarski. 2019;46:239-242.
    Abstract    

    Abstract available

  18. DEHHAGHI M, Kazemi Shariat Panahi H, Guillemin GJ
    Microorganisms, Tryptophan Metabolism, and Kynurenine Pathway: A Complex Interconnected Loop Influencing Human Health Status.
    Int J Tryptophan Res. 2019;12:1178646919852996.
    Abstract    

    Abstract available

  19. BROWN MC, Sims KJ, Gifford EJ, Goldstein KM, et al
    Gender-based Differences among 1990-1991 Gulf War Era Veterans: Demographics, Lifestyle Behaviors, and Health Conditions.
    Womens Health Issues. 2019;29 Suppl 1:S47-S55.
    Abstract    

    Abstract available

  20. RINCEL M, Darnaudery M
    Maternal separation in rodents: a journey from gut to brain and nutritional perspectives.
    Proc Nutr Soc. 2019 Jun 28:1-20. doi: 10.1017/S0029665119000958.
    Abstract    

    Abstract available

  21. GEOFFROY PA, Micoulaud Franchi JA, Lopez R, Schroder CM, et al
    The use of melatonin in adult psychiatric disorders: Expert recommendations by the French institute of medical research on sleep (SFRMS).
    Encephale. 2019 Jun 24. pii: S0013-7006(19)30180.
    Abstract    

    Abstract available

  22. SABATE JM, Riviere S, Jouet P, Gastaldi-Menager C, et al
    Healthcare use by 30,000 patients with irritable bowel syndrome (IBS) in France: a 5-year retrospective and one-year prospective national observational study.
    BMC Gastroenterol. 2019;19:111.
    Abstract    

    Abstract available

  23. MAWANI M, Azeem A, Gheewala S, Butt N, et al
    Understanding Constipation: A Cross-sectional Study from a Developing Country Setting.
    J Coll Physicians Surg Pak. 2019;29:284-286.
    Abstract    

    Abstract available

  24. LI B, Rui J, Ding X, Chen Y, et al
    Deciphering the multicomponent synergy mechanisms of SiNiSan prescription on irritable bowel syndrome using a bioinformatics/network topology based strategy.
    Phytomedicine. 2019;63:152982.
    Abstract    

    Abstract available

  25. MOAYYEDI P, Marsiglio M, Andrews CN, Graff LA, et al
    Patient Engagement and Multidisciplinary Involvement Has an Impact on Clinical Guideline Development and Decisions: A Comparison of Two Irritable Bowel Syndrome Guidelines Using the Same Data.
    J Can Assoc Gastroenterol. 2019;2:30-36.
    Abstract    

    Abstract available

  26. MOAYYEDI P, Andrews CN, MacQueen G, Korownyk C, et al
    Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS).
    J Can Assoc Gastroenterol. 2019;2:6-29.
    Abstract    

    Abstract available

  27. TANG XD, Zhang SS, Hou XH, Li ZH, et al
    Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Chin J Integr Med. 2019 Jul 10. pii: 10.1007/s11655-019-3030.
    Abstract    

    Abstract available

  28. BONAVINA L, Arini A, Ficano L, Iannuzziello D, et al
    Abincol(R) (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders.
    Acta Biomed. 2019;90.
    Abstract    

    Abstract available

  29. MASAOKA T, Kanai T
    [Current knowledge of irritable bowel syndrome -treatment].
    Nihon Shokakibyo Gakkai Zasshi. 2019;116:570-575.
    Abstract    



  30. MISHIMA Y, Ishihara S
    [Role of mucosal inflammation in irritable bowel syndrome].
    Nihon Shokakibyo Gakkai Zasshi. 2019;116:560-569.
    Abstract    



  31. NOZU T, Okumura T
    [Mechanism of visceral hypersensitivity in patients with irritable bowel syndrome].
    Nihon Shokakibyo Gakkai Zasshi. 2019;116:552-559.
    Abstract    



  32. FUKUDO S
    [Irritable bowel syndrome].
    Nihon Shokakibyo Gakkai Zasshi. 2019;116:543-551.
    Abstract    



  33. TUCK CJ, Caminero A, Jimenez Vargas NN, Soltys CL, et al
    The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome.
    Neurogastroenterol Motil. 2019 Jul 9:e13675. doi: 10.1111/nmo.13675.
    Abstract    

    Abstract available

  34. IWASAKI M, Akiba Y, Kaunitz JD
    Duodenal Chemosensing of Short-Chain Fatty Acids: Implications for GI Diseases.
    Curr Gastroenterol Rep. 2019;21:35.
    Abstract    

    Abstract available

  35. SPILLEBOUT A, Dechelotte P, Ladner J, Tavolacci MP, et al
    Mental health among university students with eating disorders and irritable bowel syndrome in France.
    Rev Epidemiol Sante Publique. 2019 Jul 6. pii: S0398-7620(19)30433.
    Abstract    

    Abstract available

  36. ENCK P, Mazurak N
    [Microbiota and irritable bowel syndrome: A critical inventory].
    Z Gastroenterol. 2019;57:859-870.
    Abstract    

    Abstract available

  37. LIANG D, Longgui N, Guoqiang X
    Efficacy of different probiotic protocols in irritable bowel syndrome: A network meta-analysis.
    Medicine (Baltimore). 2019;98:e16068.
    Abstract    

    Abstract available

  38. SUEZ J, Zmora N, Segal E, Elinav E, et al
    The pros, cons, and many unknowns of probiotics.
    Nat Med. 2019;25:716-729.
    Abstract    

    Abstract available

  39. DICKSON I
    Remotely delivered cognitive behavioural therapy superior to treatment as usual for IBS.
    Nat Rev Gastroenterol Hepatol. 2019;16:326.
    Abstract    



  40. ABHARI K, Saadati S, Hosseini-Oskouiee F, Yari Z, et al
    Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?
    Eur J Nutr. 2019 Jul 20. pii: 10.1007/s00394-019-02060.
    Abstract    

    Abstract available

  41. ARONIADIS OC, Brandt LJ, Oneto C, Feuerstadt P, et al
    Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
    Lancet Gastroenterol Hepatol. 2019 Jul 17. pii: S2468-1253(19)30198.
    Abstract    

    Abstract available

  42. BASAK S, Gicheru Y, Kapoor A, Mayer ML, et al
    Molecular mechanism of setron-mediated inhibition of full-length 5-HT3A receptor.
    Nat Commun. 2019;10:3225.
    Abstract    

    Abstract available

  43. MCNAUGHTON DT, Andreasson A, Ljotsson B, Beath AP, et al
    Effects of Psychology and Extra-Gastrointestinal Symptoms on Healthcare Use by Subjects With and Without Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2019 Jul 16. pii: S1542-3565(19)30752.
    Abstract    

    Abstract available

  44. GETACHEW B, Reyes RE, Davies DL, Tizabi Y, et al
    Moxidectin Effects on Gut Microbiota of Wistar-Kyoto Rats: Relevance to Depressive-Like Behavior.
    Clin Pharmacol Transl Med. 2019;3:134-142.
    Abstract    

    Abstract available

  45. DALE HF, Jensen C, Hausken T, Valeur J, et al
    Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome.
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  46. WALDMAN SA, Tenenbaum R, Foehl HC, Winkle P, et al
    Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation.
    Clin Transl Gastroenterol. 2019 Jul 17. doi: 10.14309/ctg.0000000000000016.
    Abstract    

    Abstract available

  47. HILLS RD JR, Pontefract BA, Mishcon HR, Black CA, et al
    Gut Microbiome: Profound Implications for Diet and Disease.
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  48. GUERREIRO M, Sousa Guerreiro C, Cravo M
    Irritable bowel syndrome: how can symptoms and quality of life be improved with diet?
    Curr Opin Clin Nutr Metab Care. 2019 Jul 10. doi: 10.1097/MCO.0000000000000589.
    Abstract    

    Abstract available

  49. BUCKLEY MM, O'Brien R, Buckley JM, O'Malley D, et al
    GHSR-1 agonist sensitizes rat colonic intrinsic and extrinsic neurons to exendin-4: A role in the manifestation of postprandial gastrointestinal symptoms in irritable bowel syndrome?
    Neurogastroenterol Motil. 2019 Jul 16:e13684. doi: 10.1111/nmo.13684.
    Abstract    

    Abstract available

  50. KIM SY, Seo YS, Lee ES, Kim KN, et al
    Total Bilirubin Is Associated with Small Intestinal Bacterial Overgrowth in Diarrhea Predominant Irritable Bowel Syndrome.
    Ann Clin Lab Sci. 2019;49:344-352.
    Abstract    

    Abstract available

  51. HOU Q, Zhu S, Zhang C, Huang Y, et al
    Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice.
    Biomed Pharmacother. 2019;118:109206.
    Abstract    

    Abstract available

  52. ZHANG FM, Li S, Ding L, Xiang SH, et al
    Effectiveness of mesalazine to treat irritable bowel syndrome: A meta-analysis.
    Medicine (Baltimore). 2019;98:e16297.
    Abstract    

    Abstract available

  53. CARTER BL, Stiff RE, Elwin K, Hutchings HA, et al
    Health sequelae of human cryptosporidiosis-a 12-month prospective follow-up study.
    Eur J Clin Microbiol Infect Dis. 2019 Jul 14. pii: 10.1007/s10096-019-03603.
    Abstract    

    Abstract available

  54. BLACK CJ, Burr NE, Ford AC
    Relative Efficacy of Tegaserod in a Systematic Review and Network Meta-analysis of Licensed Therapies for Irritable Bowel Syndrome with Constipation.
    Clin Gastroenterol Hepatol. 2019 Jul 11. pii: S1542-3565(19)30740.
    Abstract    



  55. OFFEI SD, Arman HD, Yoshimoto FK
    Chemical synthesis of 7alpha-hydroxycholest-4-en-3-one, a biomarker for irritable bowel syndrome and bile acid malabsorption.
    Steroids. 2019 Jul 11:108449. doi: 10.1016/j.steroids.2019.108449.
    Abstract    

    Abstract available

  56. ZHOU S, Liu X, Wang X, Xi F, et al
    Pharmacological and non-pharmacological treatments for irritable bowel syndrome: Protocol for a systematic review and network meta-analysis.
    Medicine (Baltimore). 2019;98:e16446.
    Abstract    

    Abstract available

  57. SCHILLER LR
    Chronic Diarrhea Evaluation in the Elderly: IBS or Something Else?
    Curr Gastroenterol Rep. 2019;21:45.
    Abstract    

    Abstract available

  58. KASTL AJ JR, Terry NA, Albenberg LG, Wu GD, et al
    The structure and function of the human small intestinal microbiota: Current understanding and future directions.
    Cell Mol Gastroenterol Hepatol. 2019 Jul 22. pii: S2352-345X(19)30094.
    Abstract    

    Abstract available

  59. MA Q, Ouyang Y, Meng F, Noolvi MN, et al
    A review of pharmacological and clinical studies on the application of Shenling Baizhu San in treatment of Ulcerative colitis.
    J Ethnopharmacol. 2019 Jul 22:112105. doi: 10.1016/j.jep.2019.112105.
    Abstract    

    Abstract available

  60. JONSSON D, Bergstrom A, Algstrom I, Simon R, et al
    Visual Analysis for Understanding Irritable Bowel Syndrome.
    Adv Exp Med Biol. 2019;1156:111-122.
    Abstract    

    Abstract available

  61. PADUANO D, Cingolani A, Tanda E, Usai P, et al
    Effect of Three Diets (Low-FODMAP, Gluten-free and Balanced) on Irritable Bowel Syndrome Symptoms and Health-Related Quality of Life.
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  62. DOTHEL G, Chang L, Shih W, Barbaro MR, et al
    micro-opioid receptor, beta-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients.
    Neurogastroenterol Motil. 2019 Jul 23:e13688. doi: 10.1111/nmo.13688.
    Abstract    

    Abstract available

  63. HAYATBAKHSH MM, Gowhari Shabgah A, Pishgouyi S, Tavakol Afshari J, et al
    The Serum Levels of CCL2 and CCL16 Expression in Patients with Irritable Bowel Syndrome.
    Rep Biochem Mol Biol. 2019;8:9-14.
    Abstract    

    Abstract available

  64. BELALI N, Wathoni N, Muchtaridi M
    Advances in orally targeted drug delivery to colon.
    J Adv Pharm Technol Res. 2019;10:100-106.
    Abstract    

    Abstract available

  65. BARKIN JA, Keihanian T, Barkin JS, Antequera CM, et al
    Preferential usage of rifaximin for the treatment of hydrogen-positive smallintestinal bacterial overgrowth.
    Rev Gastroenterol Peru. 2019;39:111-115.
    Abstract    

    Abstract available

  66. SHAKYA AK, Naik RR, Almasri IM, Kaur A, et al
    Role and function of adenosine and its receptors in inflammation, neuroinflammation, IBS, autoimmune inflammatory disorders, rheumatoid arthritis and psoriasis.
    Curr Pharm Des. 2019 Jul 16. pii: CPD-EPUB-99688.
    Abstract    

    Abstract available

  67. HUANG CS, Sun YH, Wang YT, Pan YH, et al
    Repeated transcutaneous electrical nerve stimulation of nonspecific acupoints of the upper body attenuates stress-induced visceral hypersensitivity in rats.
    Auton Neurosci. 2019;220:102556.
    Abstract    

    Abstract available

  68. KROUWEL M, Jolly K, Greenfield S
    How do people with refractory irritable bowel syndrome perceive hypnotherapy?: Qualitative study.
    Complement Ther Med. 2019;45:65-70.
    Abstract    

    Abstract available

  69. DARVISHMOGHADAM S, Ansari M, Ahmadipour H, Azimipour M, et al
    Assessment of the effect of sachet formulation of almond (Amygdalus dulcis L.) on diarrhea prominent irritable bowel syndrome (IBS-D) symptoms: A clinical trial.
    Complement Ther Med. 2019;45:242-247.
    Abstract    

    Abstract available

  70. NILHOLM C, Roth B, Ohlsson B
    A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients.
    Nutrients. 2019;11.
    Abstract    

    Abstract available

  71. SIMON RA, Engstrom M, Icenhour A, Lowen M, et al
    On Functional Connectivity and Symptom Relief After Gut-directed Hypnotherapy in Irritable Bowel Syndrome: A Preliminary Study.
    J Neurogastroenterol Motil. 2019;25:478-479.
    Abstract    



  72. CHEN X, Luo Q, Yan X, Li W, et al
    Vagal Transient Receptor Potential Ankyrin 1 Mediates Stress-exacerbated Visceral Mechanonociception After Antral Cold Exposure.
    J Neurogastroenterol Motil. 2019;25:442-460.
    Abstract    

    Abstract available

  73. GWEE KA, Gonlachanvit S, Ghoshal UC, Chua ASB, et al
    Second Asian Consensus on Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2019;25:343-362.
    Abstract    

    Abstract available

  74. CREED F
    Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies.
    Aliment Pharmacol Ther. 2019 Jul 17. doi: 10.1111/apt.15396.
    Abstract    

    Abstract available

  75. WANG XJ, Camilleri M, Vanner S, Tuck C, et al
    Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction.
    Aliment Pharmacol Ther. 2019 Jul 15. doi: 10.1111/apt.15419.
    Abstract    

    Abstract available

  76. GUNN D, Garsed K, Lam C, Singh G, et al
    Abnormalities of mucosal serotonin metabolism and 5-HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron.
    Aliment Pharmacol Ther. 2019 Jul 24. doi: 10.1111/apt.15420.
    Abstract    

    Abstract available

  77. GO GY, Park H
    Effects of Auricular Acupressure on Women With Irritable Bowel Syndrome.
    Gastroenterol Nurs. 2019 Jun 25. doi: 10.1097/SGA.0000000000000332.
    Abstract    

    Abstract available

  78. FUKUDO S, Kaku K
    Future Possibility of Mizagliflozin on Functional Constipation and/or Irritable Bowel Syndrome with Constipation.
    Gastroenterology. 2019 Jun 19. pii: S0016-5085(19)41025.
    Abstract    




  79. Irritable Bowel Syndrome in Adults (IBS-D): Clinical Decision Support Tool.
    Gastroenterology. 2019 Jul 16. pii: S0016-5085(19)41088.
    Abstract    



  80. SMALLEY W, Falck-Ytter C, Carrasco-Labra A, Wani S, et al
    American Gastroenterological Association Guideline on Mild-to-Moderate Ulcerative Colitis on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
    Gastroenterology. 2019 Jul 11. pii: S0016-5085(19)41083.
    Abstract    



  81. HUSEIN DM, Naim HY
    Impaired cell surface expression and digestive function of sucrase-isomaltase gene variants are associated with reduced efficacy of low FODMAPs diet in patients with IBS-D.
    Gut. 2019 Jul 22. pii: gutjnl-2019-319411. doi: 10.1136/gutjnl-2019-319411.
    Abstract    



  82. GOYAL O, Bansal M, Sood A
    Clinical and anorectal manometry profile of patients with functional constipation and constipation-predominant irritable bowel syndrome.
    Indian J Gastroenterol. 2019 Jun 25. pii: 10.1007/s12664-019-00953.
    Abstract    

    Abstract available

  83. SINGH P, Duehren S, Katon J, Rangan V, et al
    Breath Methane Does Not Correlate With Constipation Severity or Bloating in Patients With Constipation.
    J Clin Gastroenterol. 2019 Jul 12. doi: 10.1097/MCG.0000000000001239.
    Abstract    

    Abstract available

  84. BARAM MA, Abbasnezhad A, Ghanadi K, Anbari K, et al
    Serum Levels of Chemerin, Apelin, and Adiponectin in Relation to Clinical Symptoms, Quality of Life, and Psychological Factors in Irritable Bowel Syndrome.
    J Clin Gastroenterol. 2019 Jul 12. doi: 10.1097/MCG.0000000000001227.
    Abstract    

    Abstract available

  85. STASI C, Caserta A, Nisita C, Cortopassi S, et al
    The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment.
    J Gastroenterol Hepatol. 2019;34:713-719.
    Abstract    

    Abstract available

  86. NOCERINO R, Di Costanzo M, Bedogni G, Cosenza L, et al
    Dietary Treatment with Extensively Hydrolyzed Casein Formula Containing the Probiotic Lactobacillus rhamnosus GG Prevents the Occurrence of Functional Gastrointestinal Disorders in Children with Cow's Milk Allergy.
    J Pediatr. 2019 Jul 18. pii: S0022-3476(19)30698.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;